
Cigna raises 2026 EPS guidance, maintains Buy rating despite PBM margin pressures.
Cigna Group continues to show strong earnings and has raised its adjusted EPS guidance for 2026 to at least $30.60, targeting 10% EPS growth in 2027. While the healthcare segment's margins improved, the pharmacy benefit management (PBM) segment faces...

